Clarke Blames Sub-Prime For Man IPO Woe

Jul 20 2007 | 8:25am ET

Man Group CEO Peter Clarke blamed fears of a credit crunch resulting from the growing sub-prime mortgage debacle for the failure of the MF Global initial public offering to achieve its sale price. But he defended his decision to go forward with the sale in spite of the unfavorable conditions.

“The strategy was more important than the last dollar on the share price,” he told The Times of London.

“The exit multiple of 23 times underlying earnings is a compelling price for a separation,” he argued in a separate interview with Reuters. “It's the best price for shareholders in this environment.”

MF Global, Man’s futures brokerage, raised $2.9 billion in a float on the New York Stock Exchange yesterday. Man priced the shares at $30 each, well below its projected range of $36 to $39. In their first day of trading, MF Global shares dropped a further 8%.

Clarke said growing fears about the sub-prime mortgage market were to blame.

“What you have seen since [four weeks ago], particularly in the U.S., is concerns that started in the sub-prime mortgage market expanding across financial institutions,” he told The Times. “We were trying to sell into an environment of weakness. The timing might have been better—a week earlier, two weeks later—but the reason for floating was strategic, not financial.”

Man still owns 20% of MF Global, but Clarke said the firm would sell the remaining stake “over time.”


In Depth

GSAM's Papagiannis: Liquid Alternatives For The Long Run

Apr 21 2017 | 8:44pm ET

Interest in liquid alternatives cooled a bit last year amid a broad shift in investor...

Lifestyle

Aston Martin Returns To Debt Market As DB11 Drives Turnaround

Mar 31 2017 | 5:21pm ET

James Bond’s preferred carmaker is returning to the public debt markets for the...

Guest Contributor

Debunking Conventional Investment Wisdom (Part II)

Apr 17 2017 | 5:56pm ET

The alternative investment industry is currently replete with buzzwords around data...

 

From the current issue of